摘要
目的:研究明目地黄丸对糖尿病视网膜病变(DR)的疗效。方法:选取2009年5月～2011年5月我院门诊就诊的DR患者80例,随机将入选患者分为治疗组和对照组,每组40例;治疗组西医规范化治疗基础上,加用明目地黄丸,6g/d,2次/d,口服;连续治疗3个月后,评价临床治疗疗效。结果:治疗组显效率为22.5%,总有效率92.5%,对照组显效率为7.5%,总有效率65.0%;治疗组的总有效率明显高于对照组,两组对照差异有统计学意义(P<0.05)。结论:故明目地黄丸治疗DR,治疗期间两组均没有出现明显的不良反应,具有副作用小,安全性高,疗效确切等优点,值得临床推广。
Objective： To study the evaluate the effects of Mingmu Dihuang pills on diabetic retinopathy （DR）. Methods： 80 cases of consecutive patients under DR was randomly divided into treated group （n=40） and control group （n=40）, and the treated （n=40） with Mingmu Dihuang pills, 6g once, twice a day; besides routine medication, treated for 3 months continuously, there were no statistical differences between the basic clinical characteristics between both groups. evaluate the value in clinical application. Results： The significant efficiency of the treated group was 22.5%, the total efficiency was 92.5%, the significant efficiency of the control group was 7.5%, the total efficiency was 65.0%. The total efficiency of treated group is obviously higher than that of the control group, two groups of control （P0.05）. Conclusion： During the treatment, two groups of all did not appear obvious adverse reaction, have little side effect, high safety, definite effect etc, and is worth clinical promotion.
出处
《中医临床研究》
2013年第11期36-37,共2页
Clinical Journal Of Chinese Medicine
